Focusing on Quality. Focusing on the Future.

At Avancen, we're working to improve patient care at the bedside through the introduction of Medication on Demand (MOD®), the "world's first" oral PCA (Patient Controlled Analgesia) device. Approved by the FDA, MOD® is currently marketed and sold to hospitals along the eastern seaboard, from Florida to New Jersey. In addition to hospital sales, clinical trials also currently underway in well-known and respected US hospitals.

Thank you to our investors who stand beside us and support our mission of providing the tools, talent and technology to benefit our hospital and healthcare customers and the patients they serve.



Investors - please use your issued username and password to initially login to this area (if you cannot locate the originally issued information, please let us know). If this is your first time logging in, you will be asked to create a personal account. For future visits, you will use your registered information to gain access to investor materials. If you have any questions or require help, please contact us. Thank you.

Investor Login